Literature DB >> 25025717

Mucus layers in inflammatory bowel disease.

Malin E V Johansson1.   

Abstract

The intestinal epithelium is covered with mucus with the main structural building block being the densely O-glycosylated MUC2 mucin. The intestinal epithelium is exposed to ingested material, our digestive machinery, and large amounts of microorganisms. Mucus is the first line of defense and aids to limit exposure to all these threats to the epithelium. In the small intestine, mucus acts as a matrix, which contains antimicrobial products, such as defensins and immunoglobulin A that limit epithelial exposure to the luminal bacteria. In the colon, the stratified inner mucus layer acts as a physical barrier excluding bacteria from the epithelium. Bacterial penetration of this normally restricted zone is observed in many colitis models and also in patients with ulcerative colitis. Mucus defects that allow bacteria to reach the epithelium and to stimulate an immune system response can lead to the development of intestinal inflammation. The current state of our knowledge concerning the function of the mucus layers and the main mucin component, MUC2, in inflammatory bowel disease is described in this review.

Entities:  

Mesh:

Year:  2014        PMID: 25025717     DOI: 10.1097/MIB.0000000000000117

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  40 in total

1.  Mucosal Barrier Depletion and Loss of Bacterial Diversity are Primary Abnormalities in Paediatric Ulcerative Colitis.

Authors:  Misagh Alipour; Deenaz Zaidi; Rosica Valcheva; Juan Jovel; Inés Martínez; Consolato Sergi; Jens Walter; Andrew L Mason; Gane Ka-Shu Wong; Levinus A Dieleman; Matthew W Carroll; Hien Q Huynh; Eytan Wine
Journal:  J Crohns Colitis       Date:  2015-12-09       Impact factor: 9.071

2.  Intestinal barrier analysis by assessment of mucins, tight junctions, and α-defensins in healthy C57BL/6J and BALB/cJ mice.

Authors:  Valentina Volynets; Andreas Rings; Gyöngyi Bárdos; Maureen J Ostaff; Jan Wehkamp; Stephan C Bischoff
Journal:  Tissue Barriers       Date:  2016-07-08

3.  Nanoparticulate Drug Delivery Systems Targeting Inflammation for Treatment of Inflammatory Bowel Disease.

Authors:  Sufeng Zhang; Robert Langer; Giovanni Traverso
Journal:  Nano Today       Date:  2017-10-09       Impact factor: 20.722

4.  Metabolic control of T cell immune response through glycans in inflammatory bowel disease.

Authors:  Ana M Dias; Alexandra Correia; Márcia S Pereira; Catarina R Almeida; Inês Alves; Vanda Pinto; Telmo A Catarino; Nuno Mendes; Magdalena Leander; M Teresa Oliva-Teles; Luís Maia; Cristina Delerue-Matos; Naoyuki Taniguchi; Margarida Lima; Isabel Pedroto; Ricardo Marcos-Pinto; Paula Lago; Celso A Reis; Manuel Vilanova; Salomé S Pinho
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-02       Impact factor: 11.205

5.  Intestinal anti-inflammatory effects of probiotics in DNBS-colitis via modulation of gut microbiota and microRNAs.

Authors:  Rocío Morón; Alba Rodríguez-Nogales; Francesca Algieri; José Garrido-Mesa; Teresa Vezza; María Jesús Rodríguez-Sojo; María Elena Rodríguez-Cabezas; Mónica Olivares; Federico García; Julio Gálvez
Journal:  Eur J Nutr       Date:  2020-11-20       Impact factor: 5.614

6.  Baicalin alleviates TNBS-induced colitis by inhibiting PI3K/AKT pathway activation.

Authors:  Lei Zhu; Hong Shen; Pei-Qing Gu; Ya-Jun Liu; Lu Zhang; Jia-Fei Cheng
Journal:  Exp Ther Med       Date:  2020-05-06       Impact factor: 2.447

7.  A glycal-based photoaffinity probe that enriches sialic acid binding proteins.

Authors:  Peter S Thuy-Boun; Dennis W Wolan
Journal:  Bioorg Med Chem Lett       Date:  2019-08-01       Impact factor: 2.823

8.  Beneficial Effects of Fecal Microbiota Transplantation on Ulcerative Colitis in Mice.

Authors:  Zhihui Tian; Jie Liu; Mengyu Liao; Wenjuan Li; Jiaqi Zou; Xinxin Han; Mingjie Kuang; Wanqiu Shen; Haidong Li
Journal:  Dig Dis Sci       Date:  2016-02-05       Impact factor: 3.199

9.  Characterization of mucin gene expression and goblet cell proportion in inflammatory colorectal polyps in miniature dachshunds.

Authors:  Noriyuki Nagata; Hiroshi Ohta; Nozomu Yokoyama; Yong Bin Teoh; Noboru Sasaki; Kensuke Nakamura; Mitsuyoshi Takiguchi
Journal:  J Vet Med Sci       Date:  2022-05-05       Impact factor: 1.105

10.  Total Flavone of Abelmoschus manihot Ameliorates Stress-Induced Microbial Alterations Drive Intestinal Barrier Injury in DSS Colitis.

Authors:  Rong Wang; Tuo Chen; Qiong Wang; Xiao-Min Yuan; Zheng-Lan Duan; Ze-Yu Feng; Yang Ding; Fan Bu; Guo-Ping Shi; Yu-Gen Chen
Journal:  Drug Des Devel Ther       Date:  2021-07-08       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.